Differently, we showed that ADAR3 is down-expressed in adult GBM due to the deletion involving its genomic locus, with only really limited cancer samples (~ 2.1% of GBMs) carrying a gene gain/amplification. This evidence concerns the gene ADARB2 and glioblastoma.